| Arrythmia | Cardiac disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Atrial Fibrillation | Cardiac disorders | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Atrial Tachycardia | Cardiac disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Bradycardia | Cardiac disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Cardiac Failure | Cardiac disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Cardiac Failure Congestive | Cardiac disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Coronary Artery Disease | Cardiac disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Pyloric Stenosis | Congenital, familial and genetic disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Abdominal Hernia | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Abdominal Pain | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0003 events3 affected1,495 at risk
|
| Ascites | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Colitis Ulcerative | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Constipation | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Duodenal Ulcer | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Enterocutaneous fistula | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Gastrointestinal Wall Thickening | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Ileus | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0006 events6 affected1,495 at risk
|
| Impaired Gastric Emptying | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Intestinal obstruction | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Intra-abdominal haemorrhage | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Pancreatitis Acute | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Peritoneal Haemorrhage | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Small Intestinal Obstruction | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Subileus | Gastrointestinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Adverse drug reaction | General disorders | MedDRA (20.0) | Systematic Assessment | Opioid related side effect | - EG0001 events1 affected1,495 at risk
|
| Chest Pain | General disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Oedema peripheral | General disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Systematic inflammatory response syndrome | General disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Hepatic Function Abnormal | Hepatobiliary disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Portal Vein Thrombosis | Hepatobiliary disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Abdominal Abscess | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Abdominal Infection | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Abdominal wall abscess | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Abscess | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Abscess soft tissue | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Cellulitis | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Colonic Abscess | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Device related infection | Infections and infestations | MedDRA (20.0) | Systematic Assessment | Hip Implants (2), PICC Line (1) | - EG0003 events3 affected1,495 at risk
|
| Incision Site Cellulitis | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Infection | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Perineal Abscess | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Peritonitis | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Pneumonia | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0008 events8 affected1,495 at risk
|
| Post Procedural Infection | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Post Procedural Sepsis | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Postoperative Wound Infection | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0006 events6 affected1,495 at risk
|
| Polynephritis Acute | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Sepsis | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0003 events3 affected1,495 at risk
|
| Sepsis Syndrome | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Staphylococcal Infection | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Stoma Site Cellulitis | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Urinary Tract Infection | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Urosepsis | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Viral Upper Respiratory Tract Infection | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Wound Abscess | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Wound Infection | Infections and infestations | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Anastomotic complication | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Anastomotic lead | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Arterial injury | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Gastrointestinal anastomotic leak | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Infusion related reaction | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Joint Dislocation | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0003 events3 affected1,495 at risk
|
| Pancreatic Leak | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Post procedural bile leak | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Post Procedural complication | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Post procedural haematoma | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Postoperative ileus | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Procedural complication | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Procedural Pain | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Procedural Vomiting | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Seroma | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Stoma Site ischaemia | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Vascular pseudoaneurysm | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Wound Complication | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Wound evisceration | Injury, poisoning and procedural complications | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Breath sounds abnormal | Investigations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Liver Function Test Abnormal | Investigations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Oxygen Saturation decreased | Investigations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Diabetic ketoacidosis | Metabolism and nutrition disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Hypercalcaemia | Metabolism and nutrition disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Hyperglycaemia | Metabolism and nutrition disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Hypokalaemia | Investigations | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Hypomagnesaemia | Metabolism and nutrition disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Metabolic acidosis | Metabolism and nutrition disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Arthritis | Musculoskeletal and connective tissue disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Muscle Spasms | Musculoskeletal and connective tissue disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Spinal instability | Musculoskeletal and connective tissue disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Malignant neoplasm progression | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Metastatic neoplasm | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Renal Cancer | Neoplasms benign, malignant and unspecified (incl cysts and polyps) | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Cerebral small vessel ischaemic disease | Nervous system disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Cerebrovascular accident | Nervous system disorders | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Paraesthesia | Nervous system disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Somnolence | Nervous system disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Syncope | Nervous system disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Device Disclocation | Product Issues | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Delirium | Psychiatric disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Haematuria | Renal and urinary disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Renal Injury | Renal and urinary disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Urinary retention | Renal and urinary disorders | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Menorrhagia | Reproductive system and breast disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Acute Respiratory Failure | Respiratory, thoracic and mediastinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Dyspnoea | Respiratory, thoracic and mediastinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Hypoxia | Respiratory, thoracic and mediastinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0003 events3 affected1,495 at risk
|
| Pleural effusion | Respiratory, thoracic and mediastinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Pneumonia aspiration | Respiratory, thoracic and mediastinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Pneumothorax | Respiratory, thoracic and mediastinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Pulmonary embolism | Respiratory, thoracic and mediastinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|
| Respiratory depression | Respiratory, thoracic and mediastinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Respiratory Failure | Respiratory, thoracic and mediastinal disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Colostomy closure | Surgical and medical procedures | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Hospitalisation | Surgical and medical procedures | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Wound closure | Surgical and medical procedures | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Deep vein thrombosis | Vascular disorders | MedDRA (20.0) | Systematic Assessment | | - EG0001 events1 affected1,495 at risk
|
| Hypotension | Vascular disorders | MedDRA (20.0) | Systematic Assessment | | - EG0002 events2 affected1,495 at risk
|